Perrigo Company Announces FDA Final Approval For The Store Brand Equivalent To Children's Zyrtec® Allergy Syrup, 1 mg/mL

Perrigo Company Announces FDA Final Approval For The Store Brand Equivalent To
                  Children's Zyrtec® Allergy Syrup, 1 mg/mL

PR Newswire

ALLEGAN, Mich., Sept. 10, 2013

ALLEGAN, Mich., Sept.10, 2013 /PRNewswire/ --Perrigo Company (NYSE: PRGO;
TASE) today announced that it has received final approval from the U.S. Food
and Drug Administration for its abbreviated new drug application for
cetirizine hydrochloride oral solution USP, 1 mg/mL, bubble gum flavored, the
store brand equivalent to Children's Zyrtec® Allergy Syrup, 1 mg/mL, bubble
gum flavored. Perrigo expects to begin shipments of the product during the
upcoming cough/cold/flu season.

(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )

Children's Zyrtec® Allergy Syrup, 1 mg/mL, bubble gum flavored, (cetirizine
hydrochloride oral solution USP, 1 mg/mL, bubble gum flavored) is indicated
for Indoor and outdoor allergies in children 2 years of age and older and is
part of the overall Zyrtec® brand with estimated annual sales of approximately
$380 million.

Perrigo's Chairman, President and CEO Joseph C. Papa stated, "This approval
strengthens our leading store brand position and highlights our commitment to
bringing new products to the market."

From its beginnings as a packager of generic home remedies in 1887, Allegan,
Michigan-based Perrigo Company has grown to become a leading global provider
of quality, affordable healthcare products. Perrigo develops, manufactures and
distributes over-the-counter (OTC) and generic prescription (Rx)
pharmaceuticals, infant formulas, nutritional products, animal health, dietary
supplements and active pharmaceutical ingredients (API). The Company is the
world's largest manufacturer of OTC pharmaceutical products for the store
brand market. The Company's primary markets and locations of logistics
operations have evolved over the years to include the United States, Israel,
Mexico, the United Kingdom, India, China and Australia. Visit Perrigo on the
Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements
within the meaning of Section 21E of the Securities Exchange Act of 1934, as
amended, and are subject to the safe harbor created thereby. These statements
relate to future events or the Company's future financial performance and
involve known and unknown risks, uncertainties and other factors that may
cause the actual results, levels of activity, performance or achievements of
the Company or its industry to be materially different from those expressed or
implied by any forward-looking statements. In some cases, forward-looking
statements can be identified by terminology such as "may," "will," "could,"
"would," "should," "expect," "plan," "anticipate," "intend," "believe,"
"estimate," "predict," "potential" or other comparable terminology. The
Company has based these forward-looking statements on its current
expectations, assumptions, estimates and projections. While the Company
believes these expectations, assumptions, estimates and projections are
reasonable, such forward-looking statements are only predictions and involve
known and unknown risks and uncertainties, many of which are beyond the
Company's control. These and other important factors, including those
discussed under "Risk Factors" in the Company's Form 10-K for the year ended
June 30, 2012, as well as the Company's subsequent filings with the Securities
and Exchange Commission, may cause actual results, performance or achievements
to differ materially from those expressed or implied by these forward-looking
statements. The forward-looking statements in this press release are made only
as of the date hereof, and unless otherwise required by applicable securities
laws, the Company disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new information, future
events or otherwise.

SOURCE Perrigo Company

Contact: Arthur J. Shannon, Vice President, Investor Relations and Global
Communications, (269) 686-1709, ajshannon@perrigo.com, or Bradley Joseph,
Senior Manager, Investor Relations and Global Communications, (269) 686-3373,
bradley.joseph@perrigo.com
 
Press spacebar to pause and continue. Press esc to stop.